Exagen (XGN) Payables (2018 - 2026)

Exagen has reported Payables for 9 years, with the latest figure at $4.2 million in Q1 2026.

• For the quarter ending Q1 2026, Payables fell 7.76% year-over-year to $4.2 million; the trailing twelve-month figure through Mar 2026 stood at $4.2 million (down 7.76% YoY), and the FY2025 full-year result was $4.2 million, changed 0.39% from the prior year.
• Payables for Q1 2026 stood at $4.2 million, roughly flat from $4.2 million in the prior quarter.
• The five-year high for Payables was $4.5 million in Q1 2025, with the low at $1.1 million in Q3 2024.
• Historically, Payables has averaged $2.9 million across 5 years, with a median of $3.1 million in 2022.
• Annual changes were most pronounced in 2023 — Payables sank 57.84% — and 2025, when it jumped 222.08%.
• Exagen's Payables stood at $3.0 million in 2022, then advanced by 2.79% to $3.1 million in 2023, then soared by 32.13% to $4.1 million in 2024, then climbed by 0.39% to $4.2 million in 2025, then advanced by 0.14% to $4.2 million in 2026.
• The last three Payables figures came in at $4.2 million (Q1 2026), $4.2 million (Q4 2025), and $3.6 million (Q3 2025), per Business Quant data.